218 related articles for article (PubMed ID: 22035236)
21. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases.
Operario DJ; Reynolds HM; Kim B
Virology; 2005 Apr; 335(1):106-21. PubMed ID: 15823610
[TBL] [Abstract][Full Text] [Related]
22. Temperature effects on the fidelity of a thermostable HIV-1 reverse transcriptase.
Álvarez M; Menéndez-Arias L
FEBS J; 2014 Jan; 281(1):342-51. PubMed ID: 24279450
[TBL] [Abstract][Full Text] [Related]
23. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro.
Klarmann GJ; Schauber CA; Preston BD
J Biol Chem; 1993 May; 268(13):9793-802. PubMed ID: 7683663
[TBL] [Abstract][Full Text] [Related]
24. Analysis of nucleotide insertion and extension at 8-oxo-7,8-dihydroguanine by replicative T7 polymerase exo- and human immunodeficiency virus-1 reverse transcriptase using steady-state and pre-steady-state kinetics.
Furge LL; Guengerich FP
Biochemistry; 1997 May; 36(21):6475-87. PubMed ID: 9174365
[TBL] [Abstract][Full Text] [Related]
25. The reverse transcriptase encoded by the non-LTR retrotransposon R2 is as error-prone as that encoded by HIV-1.
Jamburuthugoda VK; Eickbush TH
J Mol Biol; 2011 Apr; 407(5):661-72. PubMed ID: 21320510
[TBL] [Abstract][Full Text] [Related]
26. De novo and DNA primer-mediated initiation of cDNA synthesis by the mauriceville retroplasmid reverse transcriptase involve recognition of a 3' CCA sequence.
Chen B; Lambowitz AM
J Mol Biol; 1997 Aug; 271(3):311-32. PubMed ID: 9268661
[TBL] [Abstract][Full Text] [Related]
27. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
28. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
29. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
30. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Loya S; Bakhanashvili M; Kashman Y; Hizi A
Arch Biochem Biophys; 1995 Feb; 316(2):789-96. PubMed ID: 7532386
[TBL] [Abstract][Full Text] [Related]
31. Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate.
Wöhrl BM; Krebs R; Goody RS; Restle T
J Mol Biol; 1999 Sep; 292(2):333-44. PubMed ID: 10493879
[TBL] [Abstract][Full Text] [Related]
32. Relaxed primer specificity associated with reverse transcriptases encoded by the pFOXC retroplasmids of Fusarium oxysporum.
Simpson EB; Ross SL; Marchetti SE; Kennell JC
Eukaryot Cell; 2004 Dec; 3(6):1589-600. PubMed ID: 15590832
[TBL] [Abstract][Full Text] [Related]
33. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
34. DNA synthesis fidelity by the reverse transcriptase of the yeast retrotransposon Ty1.
Boutabout M; Wilhelm M; Wilhelm FX
Nucleic Acids Res; 2001 Jun; 29(11):2217-22. PubMed ID: 11376139
[TBL] [Abstract][Full Text] [Related]
35. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase.
Suo Z; Johnson KA
Biochemistry; 1997 Oct; 36(41):12459-67. PubMed ID: 9376350
[TBL] [Abstract][Full Text] [Related]
36. Non-cognate template usage and alternative priming by a group II intron-encoded reverse transcriptase.
Morozova T; Seo W; Zimmerly S
J Mol Biol; 2002 Feb; 315(5):951-63. PubMed ID: 11827468
[TBL] [Abstract][Full Text] [Related]
37. Separable structural requirements for cDNA synthesis, nontemplated extension, and template jumping by a non-LTR retroelement reverse transcriptase.
Pimentel SC; Upton HE; Collins K
J Biol Chem; 2022 Mar; 298(3):101624. PubMed ID: 35065960
[TBL] [Abstract][Full Text] [Related]
38. Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein.
Bampi C; Bibillo A; Wendeler M; Divita G; Gorelick RJ; Le Grice SF; Darlix JL
J Biol Chem; 2006 Apr; 281(17):11736-43. PubMed ID: 16500895
[TBL] [Abstract][Full Text] [Related]
39. Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract.
Nair GR; Dash C; Le Grice SF; DeStefano JJ
PLoS One; 2012; 7(7):e41712. PubMed ID: 22848574
[TBL] [Abstract][Full Text] [Related]
40. Lysine 152 of MuLV reverse transcriptase is required for the integrity of the active site.
Shi Q; Singh K; Srivastava A; Kaushik N; Modak MJ
Biochemistry; 2002 Dec; 41(50):14831-42. PubMed ID: 12475231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]